109 related articles for article (PubMed ID: 7610618)
1. [Current issues in the chemotherapy of malignant tumors. Taxol (paclitaxel), Taxoter].
Gorbunova VA; Garin AM; Tiuliandin SA; Orel NF; Roshchin EM; Voĭnarevich OA
Vopr Onkol; 1994; 40(7-12):259-66. PubMed ID: 7610618
[No Abstract] [Full Text] [Related]
2. Paclitaxel (Taxol) in breast cancer.
Arbuck SG; Dorr A; Friedman MA
Hematol Oncol Clin North Am; 1994 Feb; 8(1):121-40. PubMed ID: 7908664
[TBL] [Abstract][Full Text] [Related]
3. Clinical development of Taxol.
Arbuck SG; Christian MC; Fisherman JS; Cazenave LA; Sarosy G; Suffness M; Adams J; Canetta R; Cole KE; Friedman MA
J Natl Cancer Inst Monogr; 1993; (15):11-24. PubMed ID: 7912517
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek R; Vorlicek J; Slavik M
Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
[TBL] [Abstract][Full Text] [Related]
5. The current state of adjuvant therapy for breast cancer: focus on paclitaxel.
Hudis CA
Semin Oncol; 1999 Feb; 26(1 Suppl 2):1-5. PubMed ID: 10190778
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials referral resource. Update on taxol trials.
Cheson BD
Oncology (Williston Park); 1993 Jan; 7(1):63, 66-7. PubMed ID: 8093592
[No Abstract] [Full Text] [Related]
7. The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Hortobagyi GN; Holmes FA; Ibrahim N; Champlin R; Buzdar AU
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S30-3. PubMed ID: 9071338
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel: current developmental approaches of the National Cancer Institute.
Arbuck SG
Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
[TBL] [Abstract][Full Text] [Related]
9. The clinical pharmacology of paclitaxel (Taxol).
Rowinsky EK; Donehower RC
Semin Oncol; 1993 Aug; 20(4 Suppl 3):16-25. PubMed ID: 8102014
[TBL] [Abstract][Full Text] [Related]
10. [Favorable remission rates of metastatic breast cancer with taxol therapy].
Med Klin Suppl; 1993 Nov; 2():10-3. PubMed ID: 7904714
[No Abstract] [Full Text] [Related]
11. Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture.
Wall ME; Wani MC
Cancer Res; 1995 Feb; 55(4):753-60. PubMed ID: 7850785
[TBL] [Abstract][Full Text] [Related]
12. Clinical trials referral resource. Clinical trials with paclitaxel in metastatic breast cancer.
Cheson BD; Abrams JS; Arbuck SG; Phillips PH
Oncology (Williston Park); 1994 Jan; 8(1):72-3, 76-7. PubMed ID: 7907222
[No Abstract] [Full Text] [Related]
13. [Paclitaxel in therapy of breast carcinoma. Value and perspectives].
Klaassen U; Seeber S
Med Klin (Munich); 1996 Dec; 91 Suppl 2():7-10. PubMed ID: 9082172
[No Abstract] [Full Text] [Related]
14. [Breast carcinoma. Preoperative chemotherapy can preserve the breast].
MMW Fortschr Med; 2002 Oct; 144(42):63. PubMed ID: 12534003
[No Abstract] [Full Text] [Related]
15. Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.
Denardo SJ; Richman CM; Kukis DL; Shen S; Lamborn KR; Miers LA; Kroger LA; Perez EA; Denardo GL
Anticancer Res; 1998; 18(6A):4011-8. PubMed ID: 9891439
[TBL] [Abstract][Full Text] [Related]
16. [Experiences with taxanes exemplified by paclitaxel (taxol) for internal medicine oncologic indications].
Klaassen U; Seeber S
Med Klin (Munich); 1994 Dec; 89(12):677-9. PubMed ID: 7870004
[No Abstract] [Full Text] [Related]
17. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
[TBL] [Abstract][Full Text] [Related]
18. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.
Sledge GW
Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029
[TBL] [Abstract][Full Text] [Related]
19. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
20. The pharmacoeconomics of cancer therapies.
Bishop JF; Macarounas-Kirchman K
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
